TAVT-119

N/A

Report date: 2025/07/04 14:11:02

Base Information

Drug NameTAVT-119
Drug Alias Nameamlodipine besylate gelTAVT-119
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsFissure in Ano
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTavanta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTavanta Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFissure in Ano
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A